A Day Up For Sierra Oncology, Inc.
Wed, Jan 26, 2022 at 05:30 PM
Sierra Oncology, Inc. (SRRA:NASDAQ) soared at $28.64, a gain of 26.3%. On Tue, Jan 25, 2022, SRRA:NASDAQ hit a New 2-Week High of $22.68. The stock got featured on our News Catalysts scanner on Tue, Jan 25, 2022 at 09:55 PM in the 'BIOTECH' category. From Tue, Jan 11, 2022, the stock recorded 33.33% Up Days and 30.00% Green Days
About Sierra Oncology, Inc. (SRRA:NASDAQ)
Sierra Oncology Inc is a clinical-stage drug development company engaged in next generation DNA Damage Response (DDR) therapeutics for the treatment of patients with cancer.
Top 10 Gainers:
- OmniLit Acquisition Corp. (OLIT:NASDAQ), 100%
- Ebang International Holdings Inc. (EBON:NASDAQ), 35.44%
- Eros STX Global Corporation A (ESGC:NYSE), 30.24%
- Sierra Oncology, Inc. (SRRA:NASDAQ), 26.28%
- K12 Inc. (LRN:NYSE), 25.04%
- Larimar Therapeutics Inc. (LRMR:NASDAQ), 21.25%
- Groupon, Inc. (GRPN:NASDAQ), 20.02%
- Huadi International Group Co. Ltd. (HUDI:NASDAQ), 19.81%
- Rani Therapeutics Holdings Inc. (RANI:NASDAQ), 19.59%
- Evolus, Inc. (EOLS:NASDAQ), 17.26%